Nazione: Armenia
Lingua: inglese
Fonte: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
fluconazole
Fareva Amboise
J02AC01
fluconazole
150mg
capsules
(1/1x1/) in blister
Prescription
Registered
2023-11-07
spcde-0v41df-kp-0 1 25.11.2020 PFIZER ((logo)) Diflucan ® SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Diflucan ® 50 mg hard capsules Diflucan ® 150 mg hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains fluconazole 50 mg Excipient with known effect: each hard capsule also contains 49.707 mg lactose monohydrate Each hard capsule contains fluconazole 150 mg Excipient with known effect: each hard capsule also contains 149,120 mg lactose monohydrate For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Hard capsule. 50 mg capsules: hard gelatine capsules No. 4 with a turquoise cap and white body, marked with the “Pfizer” logo and “FLU-50” in black. 150 mg capsules: hard gelatine capsules No. 1 with a turquoise cap and body, marked with the “Pfizer” logo and “FLU-150” in black. Capsule content: white to pale yellow powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Diflucan is indicated in the following fungal infections (see section 5.1). Diflucan is indicated in adults for the treatment of: Cryptococcal meningitis (see section 4.4). Coccidioidomycosis (see section 4.4). Invasive candidiasis. Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis. Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient. Vaginal candidiasis, acute or recurrent; when local therapy is not appropriate. Candidal balanitis when local therapy is not appropriate. Dermatomycosis including _tinea pedis_, _tinea corporis_, _tinea cruris_, _tinea versicolor_ and dermal _candida_ infections when systemic therapy is indicated. _Tinea unguinium (onychomycosis)_ when other agents are not considered appropriate. Diflucan is indicated in adults for the prophylaxis of: Relapse of cryptococcal meningitis in patients with high risk of recurrence. spcde-1v49df-kp-0 2 30.09.2022 Relapse of orop Leggi il documento completo